Effect of short‐term use of dapagliflozin on impaired awareness of hypoglycaemia in people with type 1 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of short‐term use of dapagliflozin on impaired awareness of hypoglycaemia in people with type 1 diabetes

Published:2021-08-16 Issue:11 Volume:23 Page:2582-2589
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Meijel Lian A.¹²^ORCID,Tack Cees J.¹^ORCID,Galan Bastiaan E.¹³⁴^ORCID

Affiliation:

1. Department of Internal Medicine Radboud University Medical Center Nijmegen The Netherlands

2. Department of Internal Medicine Maxima Medical Center Veldhoven The Netherlands

3. Department of Internal Medicine Maastricht University Medical Center⁺ Maastricht The Netherlands

4. CARIM School for Cardiovascular Diseases Maastricht University Maastricht The Netherlands

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14505

Reference40 articles.

1. The Barrier of Hypoglycemia in Diabetes

2. Self‐reported non‐severe hypoglycaemic events in Europe

3. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection

4. Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

5. Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes;Galan BE;Neth J Med,2006

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental pharmacological approaches to reverse impaired awareness of hypoglycemia—a review;Frontiers in Pharmacology;2024-01-23

2. Glucagon secretion and its association with glycaemic control and ketogenesis during sodium‐glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open‐label, prospective study;Diabetes, Obesity and Metabolism;2024-01-22

3. SGLT2 Inhibitors in the Management of Type 1 Diabetes (T1D): An Update on Current Evidence and Recommendations;Diabetes, Metabolic Syndrome and Obesity;2023-11

4. Current and future therapies to treat impaired awareness of hypoglycemia;Frontiers in Pharmacology;2023-10-24

5. No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM study;Diabetologia;2023-03-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3